ACI is excited to announce our upcoming Comprehensive Breast Centers of Excellence conference April 27-28, 2017. A dedicated forum to learn and network with representatives from organizations nationwide that are prepared to deliver superior service to a growing population.
Our event will be an exploration of techniques to better equip cancer centers with the latest strategies and advancements in medical technology through real case studies, research findings and organizational models from renowned cancer programs. The top breast centers in the country will showcase their successes and share strategies in achieving excellence in patient care as well as the business of breast cancer.
This year’s conference will highlight and discuss a myriad of topics that are relevant to providing ideal patient care. Topics of interest that will be introduced and discussed are the use of up-to-date methods, treatments and equipment, as well as ways to improve our treatment options in effort to continue combating breast cancer. We will also explore the benefits and impact the newest recommendations by national organizations, and updates to billing and reimbursement policies.
This two-day, case-study-based industry event will focus on implementing comprehensive breast programs and services to maximize competitive advantage, meet increased demand and exceed patient satisfaction. The goal of this event is to bring industry leaders together, highlight the best practice achievements, and discuss the current issues and developments in breast care and the cancer community.
Administrative and Clinical Leaders Representing Community Hospitals, Academic Medical Centers, Health Systems, and Long-Term Care Facilities. Primary titles include:
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Radiology Group aims to create value through innovation, growth and high earning power.
Konica Minolta is a world class provider in medical imaging and Healthcare IT. Konica Minolta’s Exa Healthcare IT platform offers true innovation with the latest technologies offering speed, security, and access. Exa features both a full mammography PACS as well as a standalone mammography viewer and handles large files such as 3D tomosynthesis with ease. Konica Minolta also offers the latest in ultrasound with the SONIMAGE HS1 and Digital Radiography technologies.
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world.
The Breast Health Collaborative of Texas (BHCTexas) is a nonprofit, statewide network of over 3000 individual and organizational breast health advocates, who are unified by a shared mission to unite the breast health community to educate, advocate, navigate and maximize resources with the vision of ensuring quality breast health care for all. BHCTexas educates through newsletters, webinars and the Annual Breast Health Summit—the only annual conference dedicated to improving breast health care for the medically underserved in Texas. BHCTexas navigates through direct Patient Navigation programs with clinical partnerships to reduce the minority and medically-underserved no-show rate for breast cancer screenings.
Cancer Network is an online resource that offers a wide range of news, information, and educational content geared toward oncology professionals. It is also home of the journal ONCOLOGY, which provides high-quality, peer-reviewed clinical articles that can be immediately applied to patient care. Cancer Network and ONCOLOGY are published by UBM Medica, one of the largest healthcare media and publishing companies in the U.S., serving the information needs of decision makers who cover the patient care spectrum.
Health Imaging is the leader in delivering news and insightful reporting for the medical imaging community. Healthcare executives and department leaders turn to us for practical insight to boost workflow, improve quality, reduce costs and manage their departments and facilities more efficiently through the use of imaging devices and image information management systems. To subscribe to our complimentary newsletter, visit subscribe.healthimaging.com.
As “The Trusted Resource for Emerging Technology and Clinical Applications in Medical Imaging and Radiation Oncology,” Imaging Technology News (ITN) showcases the latest, most innovative diagnostic & therapeutic technologies and service solutions. ITN is edited for professionals in radiology/medical imaging, therapeutic radiology, business administration and IT in hospitals, freestanding imaging and radiation oncology centers and purchasing organizations. Features include Comparison Charts, Technology Overviews, Advances In, Business & Economics, Case Studies and more.
The Inflammatory Breast Cancer Research Foundation is a grass-roots non-profit founded in 1999 to be a voice for this less common but deadly form of breast cancer. Our mission is to improve the lives of those touched by inflammatory breast cancer (IBC) through the power of action and advocacy. We do this by tenaciously fostering innovative IBC research, creatively educating stakeholders, and tirelessly advocating for both IBC patients and survivors.
More women die of breast cancer in metro Atlanta than in the United States as a whole. And that has to change. Susan G. Komen Greater Atlanta fights breast cancer on 2 fronts: (1) in metro Atlanta by providing screenings, and treatment support and education to those who need it most; and (2) globally, by funding cutting edge breast cancer research to find the cures. Thanks to our partners and supporters, our efforts are focused on reducing breast cancer deaths in the United States by 50% in the next decade.